Trade Summary

1 week ago, Levy Raphi, serving as Chief Financial Officer at Alpha Tau Medical Ltd. (DRTS), sold 17,873 shares at $13.00 per share, for a total transaction value of $232,397.26. Following this transaction, Levy Raphi now holds 90,180 shares of DRTS.

This sale represents a 16.54% decrease in Levy Raphi's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, July 2, 2026 and publicly disclosed via SEC Form 4 filing on Monday, July 6, 2026 at 11:37 AM ET, 4 days after the trade was made.

Alpha Tau Medical Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.